Korean bio platform stocks Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
12:56
Jan 21
Jan 21
Other bio platforms oversold buy opportunity.
The Alteogen shock triggered indiscriminate selling in other Korean bio-platform stocks, including ETF-related names such as ABL Bio and LigaChem Biosciences, but their own fundamentals were not impaired. He views that sympathy decline as a buying opportunity outside Alteogen.
MED
About Korean bio platform stocks Investor Commentary
Across the available history and selected sources, Buzzberg tracks Korean bio platform stocks across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Lee Jae-kyu.